Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: TRAVERE THERAPEUTICS, INC.
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2022-10-14 to 2022-12-30
Current total value of award: $236500
Description: CHENODAL 250 MG 6 DOSES